Naturally occurring benzodiazepines: Current status of research and clinical implications

European Archives of Psychiatry and Clinical Neuroscience

Volumn 250, Issue 4, 2000, Pages 194-202

  Sand, Philipp ^a   Kavvadias, Dominique ^a   Feineis, Doris ^a   Riederer, Peter ^a   Schreier, Peter ^a   Kleinschnitz, Matthias ^a   Czygan, Franz Christian ^a   Abou Mandour, Ahmed ^a   Bringmann, Gerhard ^a   Beckmann, Helmut ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Benzodiazepine receptor ligands; Benzodiazepines; Natural products; Neurotransmitters

Indexed keywords

BENZODIAZEPINE; BENZODIAZEPINE RECEPTOR; BENZODIAZEPINE RECEPTOR BLOCKING AGENT; FLUMAZENIL;

ALCOHOLISM; ANXIETY NEUROSIS; ARTICLE; DRUG MECHANISM; DRUG SYNTHESIS; GAS CHROMATOGRAPHY; HEPATIC ENCEPHALOPATHY; HUMAN; ION MONITORING; MASS SPECTROMETRY; MEDICAL RESEARCH; NEUROPSYCHIATRY; PRIORITY JOURNAL; SEIZURE; SLEEP DISORDER;

EID: 0033838679     PISSN: 09401334     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004060070024     Document Type: Article

References (108)

1. Endogenous benzodiazepine-like compounds and diazepam binding inhibitor in serum of patients with liver cirrhosis with and without overt encephalopathy
2. Reversal of hepatic coma by benzodiazepine antagonist (Ro 15-1788)
3. Effects of the benzodiazepine antagonist flumazenil in hepatic encephalopathy in humans
4. Evidence for the involvement of the benzodiazepine receptor complex in hepatic encephalopathy. Implications for treatment with benzodiazepine receptor antagonists
5. The GABAA receptor complex in hepatic encephalopathy: Autoradiographic evidence for the presence of an endogenous benzodiazepine receptor ligand
6. The pathogenesis and treatment of hepatic encephalopathy: Evidence for the involvement of benzodiazepine receptor ligands
7. The role of benzodiazepine receptor ligands in the pathogenesis of encephalopathy
8. Relationship between plasma benzodiazepine receptor ligand concentrations and severity of hepatic encephalopathy
9. Amelioration of hepatic encephalopathy by pharmacologic antagonism of the GABAsubA-benzodiazepine receptor complex in a rabbit model of fulminant hepatic failure
10. The online screening technique for urinary benzodiazepines: Comparison with EMIT, FPIA and GC-MS
11. Benzodiazepine therapy: An evaluation
12. Brain specific benzodiazepine receptors
13. A first biosynthetic proposal for the in vivo formation of naturally occurring diazepam-like benzodiazepines
14. In vivo formation of diazepam-like 1,4-benzodiazepines by Penicillium verrucosum var. verrucosum after administration of 2-aminobenzophenones and glycine
15. Determination of viridicatin in Penicillium cyclopium by capillary gas chromatography
16. Cerebral dysfunction in chronic alcoholism: Role of alcoholic liver disease
17. Testing human hair for flunitrazepam and 7-amino-flunitrazepam by GC/MS-NCI
18. Cirrhosis
19. Effect of various training procedures on performance in an elevated plus maze: Possible relation with brain regional levels of benzodiazepine-like molecules
20. Anxiogenic effects of the intraamygdala injection of flumazenil, a benzodiazepine receptor antagonist
21. Anxiety and brain benzodiazepine-like molecules
22. Influence of anxiolytic drugs on the effects of specific serotonin reuptake inhibitors in the forced swimming test in mice
23. Flumazenil associated seizure in an 11-months-old child
24. Benzodiazepines and benzodiazepine-like molecules are present in brain
25. Quantification of naturally occurring benzodiazepine-like substances in human breast milk
26. The protective effects of stress control may be mediated by increased brain levels of benzodiazepine receptor agonists
27. Human experimental psychopharmacology of benzodiazepine receptor inverse agonists and antagonists
28. Quantitation by gas chromatography with selected-ion monitoring mass spectrometry of 'natural' diazepam, N-desmethyl-diazepam and oxazepam in normal human serum
29. Successful long-term treatment of portal-systemic encephalopathy by the benzodiazepine antagonist flumazenil
30. Stress and putative endogenous ligands for benzodiazepine receptors: The importance of characteristics of the aversive situation and of differential emotionality in experimental animals
31. The benzodiazepine receptor inverse agonist RO 15-3505 reverses recent memory deficits in aged mice
32. Oxaprozin cross-reactivity in three commercial immunoassays for benzodiazepines in urine
33. Production of antibodies against benzodiazepines for competitive enzyme immunoassay detection in plant extracts
34. Improvement of hepatic encephalopathy treated with flumazenil
35. The effects of the benzodiazepine antagonist Ro 15-1788 on psychophysiological performance and subjective measures in normal subjects
36. Evidence that the amygdala is involved in benzodiazepine and serotonergic effects on punished responding but not on discrimination
37. Psychic and somatic anxiety: Worries, somatic symptoms and physiological changes
38. Flumazenil: A benzodiazepine antagonist
39. Valium: A discussion of current issues
40. GABAA receptor modulation of memory: The role of endogenous benzodiazepines
41. Analysis of anxiolytic drugs by capillary electrophoresis with bare and coated capillaries
42. Cognitive impairments of alcoholic cirrhotic patients: Correlation with endogenous benzodiazepine receptor ligands and increased affinity of platelet receptors
43. Identification of benzodiazepines in Artemisia dracunculus and Solarium tuberosum rationalizing their endogenous formation in plant tissue
44. Determination of 1,4-benzodiazepines by high-performance liquid chromatography-electrospray tandem mass spectrometry
45. 'Natural' benzodiazepines in man
46. Occurrence of 'natural' benzodiazepines
47. Screening, identification and quantitation of benzodiazepines in postmortem samples by HPLC with photodiode array detection
48. Sleep disorders and anxiety: Biochemical antecedents and pharmacological consequences
49. The use of animal models for delineating the mechanisms of anxiolytic agents
50. The amnesic action of benzodiazepines in man
51. Alcohol, the chloride ionophore and endogenous ligands for benzodiazepine receptors
52. Pharmacological management of alcohol withdrawal. A meta-analysis and evidence-based practice guideline. American society of addiction medicine working group on pharmacological management of alcohol withdrawal
53. Presence of benzodiazepine-like molecules in mammalian brain and milk
54. Benzodiazepine-like molecules, as well as other ligands for the brain benzodiazepine receptors are relatively common constituents of plants
55. Production of benzodiazepine-like compounds in bovine rumen
56. Occurrence of benzodiazepine, benzodiazepine-like molecules and other ligands for the benzodiazepine receptor in nature
57. In vivo formation of benzodiazepine-like molecules in mammalian brain
58. Pharmacotherapy in alcoholism
59. Plasma endogenous benzodiazepine-like activity in sleep disorders with excessive daytime sleepiness
60. Could an endogenous benzodiazepine ligand contribute to hepatic encephalopathy?
61. 'Endogenous' benzodiazepine activity in body fluids of patients with hepatic encephalopathy
62. The neurochemistry of anxiety: An update
63. Flumazenil provocation of panic attacks
64. Flumazenil in alcohol withdrawal
65. Flumazenil reverses the decrease in the hypnotic activity of pentobarbital by social isolation stress: Are endogenous benzodiazepine receptor ligands involved?
66. The benzodiazepine receptor: The enigma of the endogenous ligand
67. Naturally occurring benzodiazepines in human milk
68. New perspectives in benzodiazepine receptor pharmacology
69. Formation of benzodiazepine-like molecules in rat brain
70. The effects of flumazenil, Ro 15-4513 and beta CCM on the behaviour of control and stressed mice in the plus-maze test
71. Involvement of endogenous benzodiazepine receptor ligands in brain disorders: Therapeutic potential for benzodiazepine antagonists?
72. The role of endogenous benzodiazepines in physiology and pathology
73. Endogenous benzodiazepine receptor ligands in idiopathic recurring stupor
74. Endozepines: Non-benzodiazepine endogenous allosteric modulators of GABAA receptors
75. Purification of a benzodiazepine from bovine brain and detection of benzodiazepine-like immunoreactivity in human brain
76. Hinweise auf die Prasenz naturlicher Liganden des Benzodiazepinrezeptors in sterilem und nicht sterilem Pflanzengewebe
77. Circadian patterns of serum endogenous benzodiazepines
78. New findings on endogenous drug receptor ligands
79. Screening and detection of benzodiazepines - Pitfalls and clearance
80. Reversal of hepatic coma by benzodiazepine antagonist (Ro 15-1788
81. Hepatic encephalopathy and the gamma-aminobutyric acid neurotransmitter system
82. Effects of benzodiazepine and GABA antagonists on anticonflict effects of antianxiety drugs injected into the rat amygdala in a water-lick suppression test
83. Recurring consciousness disturbance with elevation of endogenous benzodiazepine-like activity
84. Chromatography of benzodiazepines
85. Anxiogenic properties of beta-CCE and FG 7142: A review of promises and pitfalls
86. Idiopathic recurring stupor. A case with possible involvement of the GABAergic system
87. Idiopathic recurring stupor
88. Stress-induced change in t-[3H]butylbicyclophosphorothionate binding to gamma-aminobutyric acid-gated chloride channel are mimicked by in vitro occupation of benzodiazepine receptors
89. The benzodiazepine/GABA receptor chloride ionophore complex as a biowarning system
90. Risks and benefits of long-term benzodiazepine use
91. Detection of desmethyldiazepam and diazepam in brain of different species and plants
92. Occurrence of 'natural' diazepam in human brain
93. Interference of common household chemicals in immunoassay methods for drugs of abuse
94. Diazepam and N-desmethyldiazepam are found in rat brain and adrenal and may be of plant origin
95. Increase of natural benzodiazepines in wheat and potato during germination
96. Presence of lorazepam in the blood plasma of drug free rats
97. Occurrence of pharmacologically active benzodiazepines in trace amounts in wheat and potato
98. Habituation and inhibitory avoidance training alter brain regional levels of benzodiazepine-like molecules and are affected by intracerebral flumazenil microinjection
99. Anxiolytic effects of benzodiazepines in amygdala-lesioned rats
100. Benzodiazepine receptor ligands are elevated in an animal model of hepatic encephalopathy: Relationship between brain concentration and severity of encephalopathy
101. Gut bacteria provide precursors of benzodiazepine receptor ligands in a rat model of hepatic encephalopathy
102. Benzodiazepines, anxiety and immunity
103. Hepatic encephalopathy in liver transplant recipients precipitated by benzodiazepines present in transfused blood
104. Benzodiazepine-like compounds in the plasma of patients with fulminant hepatic failure
105. Effects of the specific benzodiazepine antagonist Ro 15-1788 on sleep